Sign in
4

Changes in Ownership

Cabaletta Bio, Inc. Filed Acc 0000899243-20-006864

Options or other derivatives

  • Chief Financial Officer acquired 24,711 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Marda Anup Chief Financial Officer 2020-03-01 Grant or award · Stock Option (Right to Buy) +24,711 24,711 D
Loading xslF345X03/doc4.xml…